Business Description
Guerbet SA
NAICS : 334510
ISIN : FR0000032526
Share Class Description:
XPAR:GBT: Ordinary SharesCompare
Compare
Traded in other countries / regions
GBT.France4G8.Germany0ELV.UKGUERF.USA IPO Date
1989-07-27Description
Guerbet SA is a healthcare company that manufactures and markets medical imaging contrast agents destined for diagnostic purposes. Its products include medical imaging contrast products for x-ray imaging, magnetic resonance imaging, ultrasound imaging and for nuclear medicine. The company markets its products under the brand names such as Xenetix, Optiray, Oxilan, Telebrix, Lipiodol, Dotarem, Endorem, Artirem, Lumirem, and Lipiodol.
Financial Strength
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 0.24 | |||||
| Equity-to-Asset | 0.37 | |||||
| Debt-to-Equity | 1.01 | |||||
| Debt-to-EBITDA | 3.64 | |||||
| Interest Coverage | 3.68 | |||||
| Piotroski F-Score | 8/9 | |||||
| Altman Z-Score | 1.75 | |||||
| Beneish M-Score | -2.23 | |||||
| WACC vs ROIC | ||||||
Growth Rank
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 3.6 | |||||
| 3-Year EBITDA Growth Rate | 5.8 | |||||
| 3-Year EPS without NRI Growth Rate | 0.3 | |||||
| 3-Year Book Growth Rate | 1 | |||||
| Future 3-5Y Total Revenue Growth Rate | 7.61 |
Momentum Rank
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 78.41 | |||||
| 9-Day RSI | 67.74 | |||||
| 14-Day RSI | 64.29 | |||||
| 6-1 Month Momentum % | 102.44 | |||||
| 12-1 Month Momentum % | 105.12 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 2.54 | |||||
| Quick Ratio | 1.21 | |||||
| Cash Ratio | 0.4 | |||||
| Days Inventory | 527.08 | |||||
| Days Sales Outstanding | 60.55 | |||||
| Days Payable | 164.23 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Dividend Yield % | 1.41 | |||||
| Dividend Payout Ratio | 0.29 | |||||
| 3-Year Dividend Growth Rate | -10.6 | |||||
| Forward Dividend Yield % | 1.41 | |||||
| 5-Year Yield-on-Cost % | 0.97 | |||||
| Shareholder Yield % | -15.09 |
Profitability Rank
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 74.01 | |||||
| Operating Margin % | 4.92 | |||||
| Net Margin % | 3 | |||||
| FCF Margin % | -3.34 | |||||
| ROE % | 6.34 | |||||
| ROA % | 2.42 | |||||
| ROIC % | 3.51 | |||||
| ROC (Joel Greenblatt) % | 7.72 | |||||
| ROCE % | 6.42 | |||||
| Years of Profitability over Past 10-Year | 9 |
GF Value Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PE Ratio | 19.76 | |||||
| PE Ratio without NRI | 19.76 | |||||
| Shiller PE Ratio | 14.41 | |||||
| PS Ratio | 0.55 | |||||
| PB Ratio | 1.15 | |||||
| Price-to-Tangible-Book | 1.59 | |||||
| Price-to-Operating-Cash-Flow | 14.44 | |||||
| EV-to-EBIT | 17.81 | |||||
| EV-to-EBITDA | 7.01 | |||||
| EV-to-Revenue | 0.92 | |||||
| EV-to-FCF | -26.92 | |||||
| Price-to-Projected-FCF | 0.94 | |||||
| Price-to-Median-PS-Value | 0.67 | |||||
| Price-to-Graham-Number | 1.2 | |||||
| Earnings Yield (Greenblatt) % | 5.62 | |||||
| FCF Yield % | -5.96 | |||||
| Forward Rate of Return (Yacktman) % | 0.82 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Guerbet SA Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil €) | 795.654 | ||
| EPS (TTM) (€) | 1.75 | ||
| Beta | 0.88 | ||
| Volatility % | 49.78 | ||
| 14-Day RSI | 64.29 | ||
| 14-Day ATR (€) | 1.166892 | ||
| 20-Day SMA (€) | 33.875 | ||
| 12-1 Month Momentum % | 105.12 | ||
| 52-Week Range (€) | 15.48 - 35.85 | ||
| Shares Outstanding (Mil) | 12.59 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 8 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Guerbet SA Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Guerbet SA Stock Events
| Event | Date | Price(€) | ||
|---|---|---|---|---|
| No Event Data | ||||
Guerbet SA Frequently Asked Questions
What is Guerbet SA(XPAR:GBT)'s stock price today?
The current price of XPAR:GBT is €35.50. The 52 week high of XPAR:GBT is €35.85 and 52 week low is €15.48.
When is next earnings date of Guerbet SA(XPAR:GBT)?
The next earnings date of Guerbet SA(XPAR:GBT) is .
Does Guerbet SA(XPAR:GBT) pay dividends? If so, how much?
The Dividend Yield %  of Guerbet SA(XPAR:GBT) is 1.41% (As of Today), Highest Dividend Payout Ratio of Guerbet SA(XPAR:GBT) was 0.42. The lowest was 0.16. And the median was 0.28. The  Forward Dividend Yield % of Guerbet SA(XPAR:GBT) is 1.41%. For more information regarding to dividend, please check our Dividend Page.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers